BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23236666)

  • 21. Early pregnancy termination with mifepristone and misoprostol in Norway.
    Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
    Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial.
    Ayudhaya OP; Herabutya Y; Chanrachakul B; Ayuthaya NI; O-Prasertsawat P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S5-10. PubMed ID: 17726806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Good results of early medicinal pregnancy termination in a general practice on Curaçao].
    Boersma AA; Meyboom-de Jong B
    Ned Tijdschr Geneeskd; 2008 Mar; 152(9):504-8. PubMed ID: 18389885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
    Arvidsson C; Hellborg M; Gemzell-Danielsson K
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):87-91. PubMed ID: 16260342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of misoprostol in gynecology and obstetrics].
    Béchard de Spirlet M
    Gynecol Obstet Fertil; 2002 Apr; 30(4):317-24. PubMed ID: 12043508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial.
    Caliskan E; Doger E; Cakiroglu Y; Corakci A; Yucesoy I
    Eur J Contracept Reprod Health Care; 2009 Feb; 14(1):55-60. PubMed ID: 19241302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Misoprostol and pregnancy: ever-increasing indications of effective usage.
    Lokugamage AU; Refaey HE; Rodeck CH
    Curr Opin Obstet Gynecol; 2003 Dec; 15(6):513-8. PubMed ID: 14624219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects.
    Tang OS; Gemzell-Danielsson K; Ho PC
    Int J Gynaecol Obstet; 2007 Dec; 99 Suppl 2():S160-7. PubMed ID: 17963768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Off-label use of misoprostol in obstetrics and gynecology: Introduction].
    Simon EG; Marret H
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):87-102. PubMed ID: 24440000
    [No Abstract]   [Full Text] [Related]  

  • 30. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
    Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of delivery by mifepristone and misoprostol in termination of pregnancy and intrauterine fetal death: 2nd and 3rd trimester induction of labour.
    Stibbe KJ; de Weerd S
    Arch Gynecol Obstet; 2012 Sep; 286(3):795-6. PubMed ID: 22434057
    [No Abstract]   [Full Text] [Related]  

  • 32. Off-label use of misoprostol for labor induction in Germany: a national survey.
    Voigt F; Goecke TW; Najjari L; Pecks U; Maass N; Rath W
    Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():85-9. PubMed ID: 25553610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sublingual versus vaginal misoprostol for the management of missed abortion.
    Tanha FD; Feizi M; Shariat M
    J Obstet Gynaecol Res; 2010 Jun; 36(3):525-32. PubMed ID: 20598032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical treatment with misoprostol for early failure of pregnancies after assisted reproductive technology: a promising treatment option.
    Machtinger R; Stockheim D; Seidman DS; Lerner-Geva L; Dor J; Schiff E; Shulman A
    Fertil Steril; 2009 May; 91(5):1881-5. PubMed ID: 18455163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication abortion.
    Bartz D; Goldberg A
    Clin Obstet Gynecol; 2009 Jun; 52(2):140-50. PubMed ID: 19407520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current medical abortion care.
    Creinin MD
    Curr Womens Health Rep; 2003 Dec; 3(6):461-9. PubMed ID: 14613667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion.
    Dahiya K; Mann S; Nanda S
    Arch Gynecol Obstet; 2011 Jul; 284(1):59-63. PubMed ID: 20652288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Misoprostol and pregnancy.
    Goldberg AB; Greenberg MB; Darney PD
    N Engl J Med; 2001 Jan; 344(1):38-47. PubMed ID: 11136959
    [No Abstract]   [Full Text] [Related]  

  • 40. Mifepristone dose in the regimen with misoprostol for medical abortion.
    Marions L
    Contraception; 2006 Jul; 74(1):21-5. PubMed ID: 16781255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.